Form 8-K - Current report:
SEC Accession No. 0000950170-23-047013
Filing Date
2023-09-07
Accepted
2023-09-07 16:19:58
Documents
18
Period of Report
2023-08-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K impl-20230831.htm   iXBRL 8-K 104466
2 COURTESY COPY OF IMPL-8K-20230907 impl-impl-8k-20230907.pdf 8-K 173165
3 EX-10.1 impl-ex10_1.htm EX-10.1 2947128
4 EX-10.2 impl-ex10_2.htm EX-10.2 268257
5 EX-10.3 impl-ex10_3.htm EX-10.3 107736
6 EX-10.4 impl-ex10_4.htm EX-10.4 91203
7 GRAPHIC img236794628_0.jpg GRAPHIC 51099
  Complete submission text file 0000950170-23-047013.txt   4299195

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT impl-20230831_pre.xml EX-101.PRE 12037
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT impl-20230831_lab.xml EX-101.LAB 18778
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT impl-20230831.xsd EX-101.SCH 2459
12 EXTRACTED XBRL INSTANCE DOCUMENT impl-20230831_htm.xml XML 5129
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

EIN.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: 8-K | Act: 34 | File No.: 001-40353 | Film No.: 231242516
SIC: 2834 Pharmaceutical Preparations